Lung Cancer
News
Cancer may increase risk of type 2 diabetes
Study demonstrates elevated risk of developing diabetes for people with lung, pancreatic, breast, brain, urinary tract, or uterine cancers
News
Good chemo vs. bad chemo: When too much is a bad thing
Study questions the use of inpatient chemotherapy pointing to negative outcomes and high mortality among some patients.
Opinion
My picks for best of ASCO 2022
First-line treatment for colorectal cancer, possible new standard of care for breast cancer, and more.
Opinion
Adjuvant vs. neoadjuvant? What has ASCO 2022 taught us regarding resectable NSCLC?
Phase 3 trials are needed to determine whether neoadjuvant chemo/immunotherapy outperforms adjuvant chemo/immunotherapy.
News
Evidence still lacking that vitamins prevent CVD, cancer: USPSTF
In its final recommendation statement on the subject, the task force does, however, recommend against use of vitamin E and beta-carotene.
Conference Coverage
Promising treatment option for incurable lung cancer described as ‘significant’
Investigators suggest this combo should be standard therapy for NSCLC going forward.
Conference Coverage
Adagrasib shows durable benefit in KRAS-mutated NSCLC
“Our patients benefited clinically from this agent, and it appears to have improved overall survival.”
News
Immunotherapy treatment combo charts new course for resectable NSCLC treatment
Three cycles of neoadjuvant nivolumab plus chemotherapy improved long-term clinical outcomes in resectable stage IB-IIIA NSCLC.
News
Can lung cancer ID be as easy as breathing into an analyzer?
Breathomics testing is considered a promising lung cancer screening tool.
News
Some smokers don’t get lung cancer; genetics might explain it
These people have genes that help limit mutations to DNA that would turn cells malignant and make them grow into tumors.
